|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for uncollectible accounts | |||||
| Other noncash items including leases and deferred income taxes | |||||
| Stock-based compensation | |||||
| Retirement plans mark-to-market adjustments | |||||
| Goodwill and other asset impairment charges | |||||
| Separation and other costs, net of payments | |||||
| Business optimization and realignment costs, net of payments | |||||
| Changes in assets and liabilities: | |||||
| Receivables | |||||
| Other current assets | |||||
| Pension and postretirement healthcare assets and liabilities, net | |||||
| Accounts payable and other liabilities | |||||
| Other, net | |||||
| Cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Capital expenditures | |||||
| Purchase of investments | |||||
| Proceeds from sale of investments | |||||
| Proceeds from asset dispositions, and other investing activities, net | |||||
| Cash used in investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Proceeds from debt issuances | |||||
| Short-term borrowings, net | |||||
| Principal payments on debt | |||||
| Proceeds from stock issuances | |||||
| Dividends paid | |||||
| Purchase of common stock | |||||
| Other, net | |||||
| Cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...